Atypical clinical features of post COVID‐19 mucormycosis: A case series

Abstract

AbstractObjectivesThis case series aims to evaluate patients affected with post COVID‐19 mucormycosis from clinical presentation to surgical and pharmacological treatment to improve the disease prognosis.Material and MethodsThis case series was conducted at a specialized surgery hospital in Baghdad Medical City for over 10 months. Fifteen cases who had mild to severe COVID‐19 infections followed by symptoms similar to aggressive periodontitis, such as mobility and bone resorption around the multiple maxillary teeth, were included in this case series.ResultsAll patients did not receive COVID‐19 vaccination; seven had a history of diabetes mellitus type 2, another five patients had a history of diabetes‐like syndrome during the COVID‐19 infection, and the remaining three patients had no history of any systemic diseases. No intracranial involvement was seen in all patients, and bilateral sinus involvement was seen in three patients.ConclusionBeing highly suspicious of all patients affected with COVID‐19 is highly recommended to avoid the complications of the late diagnosis of mucormycosis. In addition, our knowledge and methods in diagnosing and treating classical mucormycosis should be modified regarding post COVID‐19 mucormycosis.